Boston Scientific Corp (BSX) bonds
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3047% below fair value
$43.03−0.66 (-1.51%)
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$12.62B
$1.71B due within a year
Net debt
$12.09B
After $539.00M of cash
Implied interest rate
3.15%
FY2025 interest ÷ average debt
Interest coverage
10.4×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2010
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Boston Scientific's 10-Q for the period ended Jun 30, 2026
Boston Scientific's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| 2021 Revolving Credit Agreement | – | $0 |
| 364-Day Revolving Credit Agreement | $2.00B | $0 |
| Revolving Credit Facility | $3.00B | $0 |
| Term Loan Credit Agreement | $6.00B | $0 |
| Tranche A Loan | $1.00B | – |
| Tranche B Loan | $5.00B | – |
See a number that looks wrong?